PolyPeptide Group is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.
- https://www.polypeptide.com/
- +41 435 020 580
- mediateam@polypeptide.com
- Michael Stäheli, Head of Investor Relations and Corporate Communication
